Board
Dr. Kenneth D. Legg, Ph.D.
Ken, a founder of Inverness, assumed a number of key roles associated with their intellectual property, operations, and finances. Prior to his work at Inverness, he was involved in a number of other medical diagnostics and sensing companies including Instrumentation Laboratory where he was the Director of Research. After the Inverness acquisition by J&J (NYSE: JNJ), Ken retired in 2002 from Inverness Medical Innovations (AMEX: IMA), the successor company to the acquired Inverness Medical Technology. He has over 35 years of academic and commercial experience in the medical device industry. Ken holds a Ph.D. in Analytical Chemistry from MIT and has practiced in areas in electrochemistry and spectroscopy over the years. As a member of the Board of Advisors at AgaMatrix, he guides the development of the company's intellectual property portfolio and corporate development strategy.
